Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage

European Journal of Pharmacology

Volumn 406, Issue 2, 2000, Pages 219-225

  Alafaci, Concetta ^a   Salpietro, Francesco ^a   Grasso, Giovanni ^a   Sfacteria, Alessandra ^b   Passalacqua, Marcello ^a   Morabito, Antonio ^a   Tripodo, Eliana ^a   Calapai, Gioacchino ^b   Buemi, Michele ^b   Tomasello, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Brain ischemia; Erythropoietin; Subarachnoid hemorrhage

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; HISTOLOGY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ANIMAL; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CALCIUM; ERYTHROPOIETIN, RECOMBINANT; MALE; RABBITS; SUBARACHNOID HEMORRHAGE;

EID: 0034644878     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00691-9     Document Type: Article

References (44)

1. Arthur B.A., Fergus A.H., Lanzino G., Mathys J., Kassel N.F., Lee K.S. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced arterial vasospasm in rabbit. Neurosurgery. 41:1997;1385-1392.
2. Asano T., Sano K. Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs. J. Neurosurg. 46:1977;454-466.
3. Bederson J.B., Levy A.L., Ding W.H., Kahn R., DiPerna C., Jenkins A.L., Vallabhajosyula P. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery. 42:1998;352-362.
4. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
5. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19:1999;643-651.
6. Broderick J.P., Brott T.G., Duldner J.E., Tomsick T., Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 25:1994;1342-1347.
7. Buemi M., Allegra A., Squadrito F., Buemi A.L., Laganà A., Aloisi C., Frisina N. Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock. Nephron. 65:1993;440-443.
8. Buemi M., Allegra A., Corica F., Floccari F., Davella D., Aloisi C., Calapai G., Iacopino G., Frisina N. Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. Nephrol., Dial., Transplant. 15:2000;422-423.
9. Buemi M., Grasso G., Corica F., Calapai G., Salpietro F.M., Casuscelli T., Sfacteria A., Aloisi C., Alafaci C., Sturiale A., Frisina N., Tomasello F. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur. J. Pharmacol. 392:2000;31-34.
10. Cardoso E.R., Peterson E.W., Hendelman W. Sub-pial infiltration of blood products following experimental subarachnoid haemorrhage. Acta Neurochir. 76:1985;140-144. (Wien).
11. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
12. Dorsh N.W., Branston N.M., Symon L. Intracranial pressure changes following primate subarachnoid hemorrhage. Neurol. Res. 11:1989;201-204.
13. Drejer J., Benveniste H., Diemer N.H., Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J. Neurochem. 45:1985;145-151.
14. Eckardt K.U., Kurtz A., Hirth P., Scigalla P., Wieczorek L., Bauer C. Evaluation of the stability of human erythropoietin in samples for radioimmunoassay. Klin. Wochenschr. 66:1988;241-245.
15. Fisher C.M. Clinical syndromes in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm. Clin. Neurosurg. 22:1975;117-147.
16. Goldberg M.A., Dunning S.P., Bunn H.F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science. 242:1988;1412-1415.
17. Hart M.N. Morphometry of brain parenchymal vessels following subarachnoid hemorrhage. Stroke. 11:1981;653-655.
18. Ireland W.P., MacLeod W.S. A method for finding stereotaxic coordinates from brain sections. J. Neurosci. Methods. 49:1993;93-96.
19. Jacobson L.O. Erythropoietin: structure, control of production, and function. Physiol. Rev. 72:1992;434-449.
20. Jacobson L.O., Goldwasser E., Fried W., Plzak L. Role of the kidney in erythropoiesis. Nature. 179:1957;633-634.
21. Jakobson M., Overgaard J., Marcussen E., Enevoldsen E. Relation between angiographic cerebral vasospasm and regional CBF in patients with SAH. Acta Neurol. Scand. 82:1990;109-115.
22. Juul S.E., Yachnis A.T., Rojiani A.M., Christensen R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr. Dev. Pathol. 2:1999;148-158.
23. Kassel N.F., Sasaki T., Colohan A.R.T., Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage: progress review. Stroke. 16:1985;562-572.
24. Kelly P.J., Gorten R.J., Grossman R.G., Eisenberg H.M. Cerebral perfusion, vascular spasm, and outcome in patients with ruptured intracranial aneurysms. J. Neurosurg. 47:1977;44-49.
25. Koshimura K., Murakami Y., Sohmiya M., Tanaka J., Kato Y. Effect of erythropoietin on neuronal activity. J. Neurochem. 72:1999;2565-2572.
26. Marti H.H., Gassmann M., Wenger R.H., Kvietikova I., Morganti-Kossmann M.C., Kossmann T., Trentz O., Bauer C. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int. 51:1997;416-418.
27. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas F. Jr., Tabira T., Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. J. Biol. Chem. 268:1993;11208-11216.
28. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., Sasaki R. A novel site of EPO production: oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269:1994;19488-19493.
29. McCormick P.W., McCormick J., Zabramski J.M., Spetzler R.F. Hemodynamics of subarachnoid hemorrhage arrest. J. Neurosurg. 80:1994;710-715.
30. Morishida E., Narita H., Nishida M., Kawashima N., Yamagishi K., Masuda S., Nagao M., Sasaki R. Anti-erythropoietin receptor monoclonal antibody: epitope mapping, quantification of the soluble receptor, and detection of the solubilized transmembrane receptor and the receptor-expressing cells. Blood. 88:1996;465-471.
31. Morishida E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 76:1997;105-116.
32. Nagai H., Katsumata T., Ohya M. Effect of subarachnoid hemorrhage on microcirculation in hypothalamus and brain stem of dogs. Neurochirurgia. 19:1976;135-144.
33. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., Masuda S., Sasaki R. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253:1998;26-32.
34. Sakanaka M., Wen T.C., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4640-4653.
35. Shigeno T., Fritschka E., Brock M., Schramm J., Shigeno S., Cervos-Navarro J. Cerebral edema following experimental subarachnoid hemorrhage. Stroke. 13:1982;368-379.
36. Shimada N., Graf R., Rosner G., Wakayama A., George C.P., Heiss W.D. Ischemic flow threshold for extracellular glutamate increase in cat cortex. J. Cereb. Blood Flow Metab. 9:1989;603-606.
37. Smith B. Cerebral pathology in subarachnoid hemorrhage. J. Neurol., Neurosurg. Psychiatry. 26:1963;535-539.
38. Stoltenburg-Didinger G., Schwarz K. Brain lesion secondary to subarachnoid hemorrhage due to ruptured aneurysms. Cervos-Navarro J., Ferst R. Stroke and Microcirculation. 1987;471-480 Raven Press, New York.
39. Weaver J., Fisher M. Subarachnoid hemorrhage: an update of pathogenesis and management. J. Neurol. Sci. 125:1994;119-131.
40. Weir B., Grace M., Hansen J., Rothberg C. Time course of vasospasm in man. J. Neurosurg. 48:1978;173-178.
41. Wiernsperger N., Schulz U., Gygax P. Physiological and morphometric analysis of microcirculation of the cerebral cortex under acute vasospasm. Stroke. 12:1981;624-627.
42. Yamaji R., Okada T., Moriya R., Naito M., Tsuruo T., Miyatake K., Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem. 239:1996;494-500.
43. Yoon W.H., Park S.J., Kim I.C., Lee M.G. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats. Res. Commun. Mol. Pathol. Pharmacol. 96:1997;227-240.
44. Zanjani E.D., Poster J., Burlington H., Mann L.I., Wasserman L.R. Liver as the primary site of erythropoietin formation in the fetus. J. Lab. Clin. Med. 89:1977;640-644.